Regulatory guidance for pharmaceutical companies to prepare for UK’s withdrawal from EU
EMA and European Commission publish updated Q&As
The European Medicines Agency (EMA) and the European Commission have published additional guidance to help pharmaceutical companies prepare for the United Kingdom’s withdrawal from the European Union (EU).
Companies are reminded to plan in advance for the situation that the United Kingdom (UK) will leave the EU on 29 March 2019 in order to avoid any impact on the continuous supply of medicines for human and veterinary use within the EU.
This version is an update of the initial questions-and-answers document that was published at the end of May 2017. Updates are marked ‘NEW’ and include additional information on how the UK’s withdrawal from the EU will affect marketing applications and authorisations for different types of medicinal products, for example, generic, hybrid and biosimilar medicines.
The guidance relates to both human and veterinary medicines, unless otherwise indicated.
Earlier this week, the Agency published the first version of its procedural guidance for industry which outlines the practical and simplified requirements that companies should follow to make sure that necessary changes to their marketing authorisation are made by the end of March 2019, to allow for the continued marketing of their medicine in the European Economic Area (EEA) after Brexit.
Companies are advised to regularly check EMA’s dedicated webpage on the consequences of the UK’s withdrawal from the EU.
This questions-and-answers document follows the publication of the European Commission/EMA notice to marketing authorisation holders of centrally authorised medicines for human and veterinary use on 2 May 2017.
Questions and answers related to the United Kingdom's withdrawal from the European Union with regard to the medicinal products for human and veterinary use within the framework of the centralised procedure (01/12/2017)
Latest News from
Council agrees on emergency measures to reduce energy prices03/10/2022 16:33:00
EU energy ministers recently (30 September 2022) reached a political agreement on a proposal for a Council Regulation to address high energy prices.
Guidelines on general visa issuance in relation to Russian applicants and controls of Russian citizens at the external borders03/10/2022 15:25:00
The Commission recently (30 September 2022) presented updated guidelines to Member States on visa procedures as well as on border controls for Russian citizens at the EU's external borders.
Message of President Charles Michel on Russia's illegal annexation of Ukrainian regions03/10/2022 14:33:00
Message of President Charles Michel on Russia's illegal annexation of Ukrainian regions (30 September 2022).
Ethiopia: Statement by Commissioner Lenarčič on the humanitarian situation and International Humanitarian Law in northern Ethiopia03/10/2022 13:25:00
Ethiopia: Statement given recently (30 September 2022) by Commissioner Lenarčič on the humanitarian situation and International Humanitarian Law in northern Ethiopia.
Antitrust: Commission upgrades eLeniency tool to grant companies online access to leniency and settlement documents03/10/2022 12:10:00
The European Commission has upgraded its online platform “eLeniency” to ensure that companies who are parties to cartel and antitrust proceedings can easily and securely access documents online.
State aid: Commission approves aid to support the resolution of the Polish Getin Noble Bank S.A.03/10/2022 11:33:00
The European Commission has approved, under EU State aid rules, several support measures in the context of the resolution of the Polish Getin Noble Bank S.A.
Council and Parliament reach provisional political agreement on access to Union waters, extending the current rules for fishermen for another ten years30/09/2022 15:25:00
The Czech Presidency of the Council of the European Union and the European Parliament reached a provisional political agreement as regards the regime for access of fishing vessels to member states’ territorial waters.
Ensuring radiation protection: Commission refers LATVIA to Court to guarantee citizens' protection from ionising radiation-exposure risks30/09/2022 14:33:00
The Commission is taking legal steps to ensure the protection of citizens, workers and patients against the dangers arising from exposure to ionizing radiation.
Investor citizenship scheme: Commission refers MALTA to the Court of Justice30/09/2022 13:25:00
The European Commission yesterday decided to refer Malta to the Court of Justice of the European Union for its investor citizenship scheme, also referred to as the ‘golden passports'.
Human rights: EU increases support to the protection of human rights defenders worldwide30/09/2022 12:38:00
Human rights are increasingly under threat worldwide. Against this global backdrop, reconfirming the European Union's strong support to human rights, fundamental freedoms and democracy, and their defenders worldwide, Commissioner Jutta Urpilainen yesterday signed €30 million, a substantial increase, for the new phase of the EU Human Rights Defenders Mechanism, in the presence of civil society organisations and human rights defenders, for the period 2022–2027.